Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/27/2025

Coagulation Assessment and Management

Core Coagulation Tests

  • The American College of Cardiology recommends prothrombin time (PT)/International Normalized Ratio (INR) to evaluate the extrinsic and common coagulation pathways, monitoring factors II, V, VII, and X 1, 3
  • Activated partial thromboplastin time (aPTT) assesses the intrinsic and common pathways, evaluating factors VIII, IX, XI, XII, prekallikrein, and high-molecular-weight kininogen 1, 3
  • Fibrinogen level is critical because fibrinogen is often the first coagulation factor to reach critically low levels during major bleeding 1
  • Platelet count is essential for assessing primary hemostasis and clot formation capacity 1

Viscoelastic Testing

  • Viscoelastic testing, such as thromboelastography (TEG) or rotational thromboelastometry (ROTEM), provides comprehensive real-time assessment of clot initiation, formation, strength, and breakdown 1
  • TEG or ROTEM can predict the need for massive transfusion and mortality better than standard tests in trauma and surgical patients 1
  • The American College of Cardiology suggests that TEG or ROTEM may be useful for detecting coagulation abnormalities from direct thrombin inhibitors 1

Additional Tests and Monitoring

  • For patients on anticoagulants, specialized assays for direct oral anticoagulants (DOACs) are recommended, such as dilute thrombin time or ecarin assays for dabigatran 3
  • Thrombin time (TT) can rapidly exclude clinically significant dabigatran levels if normal 3
  • Regular monitoring of platelet count, PT, D-dimer, and fibrinogen is important for diagnosing worsening coagulopathy 7

Clinical Applications and Pitfalls

  • The American College of Cardiology and other guidelines recommend not relying solely on PT and aPTT as they may not correlate with clinical bleeding risk 1, 5
  • Do not delay treatment while waiting for laboratory results in cases of severe bleeding 2, 6
  • Traditional tests were not designed to monitor coagulation deficiencies during active hemorrhage 2